ArticleFrontiers in surgery2026
Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scarless approaches are increasingly explored in the surgical management of early-stage cervical cancer. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) has been described for retroperitoneal access and, more recently, for radical hysterectomy and sentinel node biopsy. Here we report a fully transvaginal radical strategy that combines a distinct retropubic extraperitoneal corridor for vaginal endoscopic extraperitoneal lymphadenectomy (VEEL) with radical vaginal hysterectomy or trachelectomy. Case description: Five consecutive women (30-55 years) with FIGO 2018 stage IA2-IB1 cervical cancer underwent retropubic extraperitoneal VEEL followed by radical vaginal hysterectomy or radical vaginal trachelectomy. No abdominal trocar was used. Pelvic lymph node yields were 26, 21, 14, 34 and 10, respectively. At last follow-up (6-64 months), all patients were alive without evidence of disease. The most frequent postoperative morbidity was pelvic lymphocele/collections (2/5), including one symptomatic lymphocele requiring laparoscopic fenestration (Clavien-Dindo IIIb). Conclusion: Retropubic extraperitoneal VEEL combined with radical vaginal surgery may enable oncologically adequate nodal staging without abdominal scars. However, lymphocele/collections observed in this small series underscore the importance of careful patient selection, standardized lymphocele-prevention measures, and consideration of sentinel lymph node mapping to reduce lymphatic morbidity in appropriately staged early disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.